ClinicalTrials.Veeva

Menu

Improving HIV Prevention Among Heterosexual Men Seeking STI Services in Malawi (NJIRA)

H

HIV Prevention Trials Network

Status

Completed

Conditions

Systems Navigation
Pre-exposure Prophylaxis
Sexually Transmitted Infections
HIV Infection

Treatments

Other: PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines
Behavioral: Evaluation of barriers and facilitators to ongoing PrEP use
Other: PrEP eligibility assessment
Other: Tracing for any missed PrEP visits
Diagnostic Test: Rapid HIV antibody testing prior to provision and/or refill of PrEP
Other: Point of contact STI testing to inform counseling regarding ongoing PrEP care engagement
Other: Offering a PrEP "restart" kit for men who choose to discontinue PrEP during the follow-up period

Study type

Interventional

Funder types

NETWORK
Other
NIH

Identifiers

NCT06200545
UM1AI068619-17 (U.S. NIH Grant/Contract)
HPTN 112

Details and patient eligibility

About

To evaluate the potential benefit(s), acceptability, and associated costs of a systems navigator-delivered HIV prevention intervention in promoting and supporting persistent use of evidence-based HIV pre-exposure prophylaxis (PrEP) among heterosexual men receiving care for sexually transmitted infections (STIs) in Lilongwe, Malawi.

Enrollment

199 patients

Sex

Male

Ages

15+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Adult and adolescent men who meet all of the following criteria are eligible for inclusion in this study as a participant initiating PrEP:

    • Age ≥18 years, or age 15-17 (with assent and parent/guardian consent)
    • Able to provide informed consent
    • No plans to move outside study area for at least 26 weeks after study enrollment
    • Willing to provide contact/locator information, including phone number, to facilitate tracing
    • Willing to participate in study activities, including specimen collection
    • Willing to participate in study activities, including systems navigation, counseling, and point of contact STI testing
    • Sought STI clinic services within 7 days of enrollment
    • Initiated on PrEP at STI clinic within 7 days of enrollment
    • Reports at least one female sex partner in the 6 months prior to enrollment
    • Self-identifies as heterosexual
  2. Individuals who meet all of the following criteria are eligible for inclusion in this study as other key stakeholders:

    • Age ≥18 years at the enrollment visit
    • Able to provide informed consent
    • Involved in provision of clinical service navigation, systems navigation, STI or HIV care or prevention (including clinic management or oversight), or development of HIV prevention policy or programs at local or national level

Exclusion criteria

  1. Adult and adolescent men who meet any of the following criteria are ineligible for inclusion in this study as a participant initiating PrEP:

    • Appearance of psychological disturbance or cognitive impairment that would limit the ability to understand study procedures, as determined by the investigators
    • Any other condition that, in the opinion of the investigators, would make participation in the study unsafe, or otherwise interfere with the conduct of the study
    • Current participation in any HIV prevention study or other study considered to interfere the interpretation of study outcomes.
  2. Individuals who meet any of the following criteria are ineligible for inclusion in this study as other key stakeholder:

    • Appearance of psychological disturbance or cognitive impairment that would limit the ability to understand study procedures, as determined by the investigators
    • Any other condition that, in the opinion of the investigators, would make participation in the study unsafe, or otherwise interfere with the study activities

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

199 participants in 2 patient groups

Standard of care PrEP services
Active Comparator group
Description:
Standard of care (SOC) PrEP services include PrEP eligibility assessment, rapid HIV antibody testing prior to provision and/or refill of PrEP, and PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines. Specifically, SOC services do not generally include point of contact STI testing (with the exception of rapid syphilis and Hepatitis B antigen testing, if kits are available, at PrEP initiation) nor tracing for missed PrEP visits. Participants randomized to the SOC condition will receive these standard PrEP services.
Treatment:
Diagnostic Test: Rapid HIV antibody testing prior to provision and/or refill of PrEP
Other: PrEP eligibility assessment
Other: PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines
Intervention package PrEP services
Experimental group
Description:
The intervention package is integrated into PrEP visits and includes evaluation of barriers and facilitators to ongoing PrEP use, point of contact STI testing to inform counseling regarding ongoing PrEP care engagement, tracing for any missed PrEP visits, and offering a PrEP "restart" kit for men who choose to discontinue PrEP during the follow-up period. Recognizing increasingly cyclical PrEP use patterns, navigators serve as a direct entry point to retain or re-engage participants in HIV prevention care.
Treatment:
Other: Offering a PrEP "restart" kit for men who choose to discontinue PrEP during the follow-up period
Other: Point of contact STI testing to inform counseling regarding ongoing PrEP care engagement
Diagnostic Test: Rapid HIV antibody testing prior to provision and/or refill of PrEP
Other: Tracing for any missed PrEP visits
Other: PrEP eligibility assessment
Behavioral: Evaluation of barriers and facilitators to ongoing PrEP use
Other: PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Michelle Robinson; erica hamilton

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems